Trials / Completed
CompletedNCT04100044
Exercise Prescription for the Improvement of Quality of Life in Elderly Patients With Multiple Myeloma
A Pilot Study to Assess Adherence of an Exercise Prescription in Elderly Multiple Myeloma Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 9 (actual)
- Sponsor
- Thomas Jefferson University · Academic / Other
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Not accepted
Summary
This trial studies how well exercise prescription works in improving quality of life in elderly patients with multiple myeloma. Engaging and adhering to an exercise program may improve functional status and quality of life and decrease pain and skeletal-related events. This study is being done to see if elderly patients with multiple myeloma can participate in a physical activity program.
Detailed description
PRIMARY OBJECTIVE: I. Assess the ability for elderly multiple myeloma patients to maintain a personalized exercise regimen and activity level for a period of 6 months. SECONDARY OBJECTIVE: I. Assess changes in biometric data. EXPLORATORY OBJECTIVE I. Evaluate changes in bone metabolism markers as a result of exercise. OUTLINE: Patients meet with a physical therapist on day 0 and at 3 and 6 months and receive a personalized home exercise intervention consisting of aerobic and resistance training for 6 months. Patients also receive face-to-face sessions, video chats, or text message check-ins with physical therapist weekly for 6 weeks and then every other week for up to 24 weeks. After completion of study, patients are followed up every 6 months for 5 years.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Exercise Counseling | Meet with physical therapist |
| BEHAVIORAL | Exercise Intervention | Receive personalized home exercise intervention |
| OTHER | Questionnaire administration | Ancillary studies |
| OTHER | Quality-of-Life Assessment | Ancillary studies |
Timeline
- Start date
- 2019-10-24
- Primary completion
- 2022-05-27
- Completion
- 2022-05-27
- First posted
- 2019-09-23
- Last updated
- 2025-04-29
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04100044. Inclusion in this directory is not an endorsement.